FasL-PDPK1 Pathway Promotes the Cytotoxicity of CD8+ T Cells During Ischemic Stroke

Transl Stroke Res. 2020 Aug;11(4):747-761. doi: 10.1007/s12975-019-00749-0. Epub 2020 Feb 8.

Abstract

CD8+ T cells are recognized as key players in exacerbation of ischemic stroke; however, the underlying mechanism in modulating the function of CD8+ T cells has not been completely elucidated. Here, we uncovered that FasL enhanced the cytotoxicity of CD8+ T cells to neurons after ischemic stroke. Inactivation of FasL specific on CD8+ T cells protected against brain damage and neuron loss. Proteomic analysis identified that PDPK1 functioned downstream of FasL signaling and inhibition of PDPK1 effectively reduced cytotoxicity of CD8+ T cells and improved ischemic neurological deficits. Taken together, these results highlight an intrinsic FasL-PDPK1 pathway regulating the cytotoxicity of CD8+ T cells in ischemic stroke.

Keywords: CD8+ T cells; FasL; PDPK1; cytotoxicity; neurons; stroke.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Phosphoinositide-Dependent Protein Kinases / metabolism*
  • Animals
  • Apoptosis
  • Brain Ischemia / metabolism*
  • Brain Ischemia / pathology*
  • CD8-Positive T-Lymphocytes / metabolism*
  • Fas Ligand Protein / metabolism*
  • Ischemic Stroke / metabolism*
  • Ischemic Stroke / pathology*
  • Male
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurons / metabolism
  • Neurons / pathology
  • Signal Transduction

Substances

  • Fas Ligand Protein
  • Fasl protein, mouse
  • 3-Phosphoinositide-Dependent Protein Kinases
  • Pdpk1 protein, mouse